ClinicalTrials.gg
CompletedNCT05301257Updated Aug 14, 2023

SOSteniamoci: An Internet-based Intervention to Support Informal Caregivers.

An interventional study of Intervention group SOSteniamoci in Caregiver Burden, sponsored by Bar-Ilan University, Israel. Completed at 1 site in Italy. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-08-14.

Sponsored by Bar-Ilan University, Israel · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
105
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Caregiver Burden with a site in Italy — 3 open to participants now, 4 under way, none of them phase 3. Caregiver Burden · Italy.

Started
2022
with 1 other
No phase
9 of 10
3 open now
Registered
3rd of 10
by date
Lead sponsor
1 of 10
Bar-Ilan University, Israel

Among the 10 studies in Caregiver Burden with a site in Italy, this one is one of 2 that started in 2022, is one of 9 with no phase, and was the 3rd registered.

Caregiver Burden

503 studies on the registry are indexed under Caregiver Burden; 166 are open to participants now.

Browse Caregiver Burden studies →

Open to participants now

3 of the 10 studies in Caregiver Burden with a site in Italy are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 90 Caregiver Burden studies recruiting now, 69 (77%) set no upper age limit and 7 (8%) stop at 75 or younger; 8 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Caregiver Burden with a site in Italy, or all of them as a file.
02

Study summary

The purpose of this study is to evaluate efficacy of internet intervention for informal caregivers in Italy in reducing their care-giving burden.

Read the detailed description

This intervention is going to take a form of an Internet-based Intervention (IBI) consisting of eight therapeutic modules. These are the themes, as listed chronologically: Introduction, Thoughts and Acceptance, Problem Solving, Stress and relaxation, Communication, Behavioural Activation, Worry and Anxiety, Maintenance. These themes were chosen after considering topics which might be the most useful for someone in a role of an informal caregiver, considering the trans-diagnostic nature of the intervention.

Effect of the intervention will be compared against a wait-list control group. Intervention is in Italian.

03

Conditions studied

  • Caregiver Burden

Browse trials for

Keywords

  • informal caregiver
  • internet-based intervention
  • caregiver burden
  • culturally adapted
  • eHealth
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. 18 years old or over and both gender;
  2. spent at least the last couple of months providing care;
  3. must have internet access and the ability to use a computer or any other compatible device;
  4. must be able to complete a phone interview -

Exclusion criteria

Exclusion Criteria:

  1. having severe physical or mental impairments, psychiatric conditions or neurological disorders; 2) the person in need of care has a below or approximately around 6 months; 3) not able to use a computer or an electronic device; 4) not able to complete a phone interview;

-

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
105 participants (actual)

Study arms

  • Experimental
    Experimental Group SOSteniamoci

    Trans-diagnostic, 8 module, 8 week long internet intervention for reducing informal caregiver burden

    Behavioral: Intervention group SOSteniamoci

  • No intervention
    Control Group SOSteniamoci

    Participants in the control group will be instructed to wait. Once intervention group will be finished, participants in control group will be able to access the same intervention

Interventions

  • BehavioralIntervention group SOSteniamoci

    Intervention based on cognitive behavioural therapy principles and culturally adapted to Italian population. Intervention's main purpose is to reduce caregiver burden and increase quality of life. Intervention contains psycho-educational elements as well as examples and exercises.

06

What researchers measure

Primary outcomes

  1. Cargiver Burden Inventory (CBI)

    This measure is used to evaluate caregiver burden. CBI contains 24 questions that are distributed within 5 facets - Time Dependency, Emotional Health, Development, Physical Health and Social Relationships. Answer options are presented on a 5-item Likert scale and ranges from from 0 ('Never') to 4 ('Nearly Always'). Total score on CBI is summed up and ranges from 0 to 96, higher score indicating higher levels of burden experienced.

    Time frame: Pre-treatment; Week 8; 12 months post-treatment

Secondary outcomes

  1. Perceived Stress Scale (PSS-10)

    Measure will be used to evaluate levels of experienced stress. It contains 10 questions on a Likert scale ranging from 0 ('Never') to 4 ('Very Often'). Higher score indicates more severe symptoms.

    Time frame: Pre-treatment; Week 8; 12 months post-treatment

  2. The Patient Health Questionnaire (PHQ-9)

    Measure will be used to evaluate depressive symptoms. It contains 9 questions that must be responded to by choosing an answer from 4-item Likert scale, where number 0 indicates 'Not at all' and 3 - 'Nearly every day'. Higher score indicates more severe symptoms.

    Time frame: Pre-treatment; Week 8; 12 months post-treatment

  3. Generalized Anxiety Disorder (GAD-7)

    Measure will be used to evaluate caregiver anxiety. GAD-7 contains 7 questions that must be responded to by choosing an answer from 4-item Likert scale, where number 0 indicates 'Not at all' and 3 - 'Nearly every day'. Higher score indicates more severe symptoms.

    Time frame: Pre-treatment; Week 8; 12 months post-treatment

  4. World Health Organization (WHO-5)

    This questionnaire contains 5 statements regarding individual's well-being. Each of the statements must be evaluated using 6-item Likert scale with a score of 0 indicating 'At no time' while a score of 5 - 'All the time'. Higher score indicates higher well-being.

    Time frame: Pre-treatment; Week 8; 12 months post-treatment

  5. Couple Satisfaction Inventory (CSI-4)

    This questionnaire contains 4 statements regarding couple satisfaction. Each of the statements must be evaluated using a 6-item Likert scale. A higher score indicates higher couple satisfaction.

    Time frame: Pre-treatment; Week 8; 12 months post-treatment

  6. The Inclusion of Illness in the Self Scale (IIS) - Caregiver version

    This scale included a set of 7 pairs of concentric circles (one labeled 'Self' and one labeled 'Other's Illness') that vary in their degree of overlap from 1 (two separate circles) to 7 (almost completely overlapping circles).

    Time frame: Pre-treatment; Week 8; 12 months post-treatment

07

Study locations

1 site
  • Istituto Auxologico Italiano
    Milano, 20149, Italy
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2022 to primary completion in Jul 2023, 12 months.

Of 285 non-industry interventional studies with no phase under Caregiver Burden, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 31. This study's 12 months is below that.

Counting every sponsor, half of 294 studies reached it within 16 months; a quarter within 7 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 18, 2022
First posted
Mar 29, 2022
StartActual
Jul 15, 2022
Primary completionActual
Jul 15, 2023
CompletionActual
Jul 15, 2023
Last update
Aug 14, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05301257
Lead sponsor
Bar-Ilan University, Israel
Responsible party
Noa Vilchinsky (Principal Investigator, Bar-Ilan University, Israel) — Principal investigator
First posted
Mar 29, 2022
Start date
Jul 15, 2022
Primary completion
Jul 15, 2023
Completion
Jul 15, 2023
Last update
Aug 14, 2023

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion